Trials / Sponsors / Alentis Therapeutics AG
Alentis Therapeutics AG
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ So Cervical Squamous Cell Carcinoma, Squamous Non-small-cell Lung Cancer, Colorectal Cancer | Phase 1 / Phase 2 | 2025-08-26 |
| Recruiting | A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2024-12-16 |
| Terminated | Study of ALE.C04 in Patients With Head and Neck Cancer Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2023-10-30 |
| Recruiting | Rescue of Nephrons With ALE.F02 (RENAL-F02) Glomerulonephritis Rapidly Progressive | Phase 2 | 2023-09-07 |
| Completed | A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis Advanced Liver Fibrosis, Liver Cirrhosis | Phase 1 | 2023-04-01 |